A novel antiviral intervention results in more accurate assessment of human immunodeficiency virus type 1 replication dynamics and T-Cell decay in vivo

被引:300
|
作者
Markowitz, M
Louie, M
Hurley, A
Sun, E
Di Mascio, M
机构
[1] Rockefeller Univ, Aaron Diamond AIDS Res Ctr, New York, NY 10016 USA
[2] Abbott Labs, Abbott Pk, IL 60064 USA
[3] Los Alamos Natl Lab, Div Theoret, Los Alamos, NM USA
关键词
D O I
10.1128/JVI.77.8.5037-5038.2003
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Mathematical models provide an understanding of in vivo replication kinetics of human immunodeficiency virus type 1 (HIV-1). With a novel intervention designed for increased potency, we have more accurately deduced the half-lives of virus-producing CD4+ T cells, 0.7 day, and the generation time of HIV-1 in vivo, approximately 2 days, confirming the dynamic nature of HIV-1 replication.
引用
收藏
页码:5037 / 5038
页数:2
相关论文
共 50 条
  • [31] Human immunodeficiency virus type 1 replication in the absence of integrase-mediated DNA recombination: Definition of permissive and nonpermissive T-Cell lines
    Nakajima, N
    Lu, R
    Engelman, A
    JOURNAL OF VIROLOGY, 2001, 75 (17) : 7944 - 7955
  • [32] Antiviral inhibition of human T-cell leukemia virus type-1 and Rous Sarcoma Virus Capsid Proteins
    Igbinosun, OJ
    Summers, MF
    PROTEIN SCIENCE, 2004, 13 : 133 - 133
  • [33] Transfer of specificity for human immunodeficiency virus type 1 into primary human T lymphocytes by introduction of T-cell receptor genes
    Cooper, LJN
    Kalos, M
    Lewinsohn, DA
    Riddell, SR
    Greenberg, PD
    JOURNAL OF VIROLOGY, 2000, 74 (17) : 8207 - 8212
  • [34] HELPER T-CELL RESPONSES IN CHILDREN INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    ROILIDES, E
    CLERICI, M
    DEPALMA, L
    RUBIN, M
    PIZZO, PA
    SHEARER, GM
    JOURNAL OF PEDIATRICS, 1991, 118 (05): : 724 - 730
  • [35] In vivo analysis of human T-cell leukemia virus type 1 reverse transcription accuracy
    Mansky, LM
    JOURNAL OF VIROLOGY, 2000, 74 (20) : 9525 - 9531
  • [36] Induction of T-cell immunity to antiretroviral drug-resistant human immunodeficiency virus type 1
    Stratov, I
    Dale, CJ
    Chea, S
    McCluskey, J
    Kent, SJ
    JOURNAL OF VIROLOGY, 2005, 79 (12) : 7728 - 7737
  • [37] Host sequences flanking the human T-cell leukemia virus type 1 provirus in vivo
    Leclercq, I
    Mortreux, F
    Cavrois, M
    Leroy, A
    Gessain, A
    Wain-Hobson, S
    Wattel, E
    JOURNAL OF VIROLOGY, 2000, 74 (05) : 2305 - 2312
  • [38] Naive T-cell dynamics in human immunodeficiency virus type 1 infection: Effects of highly active antiretroviral therapy provide insights into the mechanisms of naive T-cell depletion
    Di Mascio, M
    Sereti, I
    Matthews, LT
    Natarajan, V
    Adelsberger, J
    Lempicki, R
    Yoder, C
    Jones, E
    Chow, C
    Metcalf, JA
    Sidorov, IA
    Dimitrov, DS
    Polis, MA
    Kovacs, JA
    JOURNAL OF VIROLOGY, 2006, 80 (06) : 2665 - 2674
  • [39] Enhanced inhibition of human immunodeficiency virus type 1 replication by novel lentiviral vectors expressing human immunodeficiency virus type 1 envelope antisense RNA
    Mautino, MR
    Morgan, RA
    HUMAN GENE THERAPY, 2002, 13 (09) : 1027 - 1037
  • [40] Human immunodeficiency virus type 1 Vpr induces DNA replication stress in vitro and in vivo
    Zimmerman, Erik S.
    Sherman, Michael P.
    Blackett, Jana L.
    Neidleman, Jason A.
    Kreis, Christophe
    Mundt, Pamela
    Williams, Samuel A.
    Warmerdam, Maria
    Kahn, James
    Hecht, Frederick M.
    Grant, Robert M.
    de Noronha, Carlos M. C.
    Weyrich, Andrew S.
    Greene, Warner C.
    Planelles, Vicente
    JOURNAL OF VIROLOGY, 2006, 80 (21) : 10407 - 10418